Correction: Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients (PLoS ONE)

Kuo K.-L.Hung S.-C.Lin Y.-P.Tang C.-F.TZONG-SHYUAN LEELin C.-P.Tarng D.-C.2020-06-302020-06-3020131932-6203https://www.scopus.com/inward/record.uri?eid=2-s2.0-84895550646&doi=10.1371%2fannotation%2f828aa889-2cb2-4bff-91d3-e247d7da2e14&partnerID=40&md5=4a350e5843c248b0c3c01426dfce343fhttps://scholars.lib.ntu.edu.tw/handle/123456789/507413Correction: Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients (PLoS ONE)corrigendum10.1371/annotation/828aa889-2cb2-4bff-91d3-e247d7da2e142-s2.0-84895550646